Share This

Hot News

【新股IPO】昭衍新藥6127招股入場費15252元A股溢價近3成- 香港經濟日報- 即時新聞頻道- 即市財經- 新股IPO @ 2021-02-17T00: Back Hot News
Keyword:新股 昭衍新藥 招股
Concept:新股昭衍新藥 , 首日招股孖展錄
新股昭衍新藥(06127)在本周二至周五招股,預計下周五在港交所掛牌。截至上午10時,綜合多間券商的數據所示,該股的孖展錄得3億元,未足額認購,券商華盛證券借出3億元。昭衍新藥A股已在上交所買賣,以前收市價161.35元(人民幣,下同)計,市值367億元,與港股招股最高價151港元,溢價約28%。該公司為藥物安全性評價方面的合同研究組織,主要業務包括非臨床研究、臨床試驗及相關服務及實驗模型業務,現正擴展以提供涵蓋藥物研發服務鏈上藥物發現、臨床前和臨床試驗階段的綜合服務。2019年收入按年增56.4%至6.4億元,純利1.9億元,同比增78.2%。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.